Showing results (171-180 of 376) with videos related to
Sort By:
Pageof 38
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2014
A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenzPere Domingo, Maria del Mar Gutierrez, José Miguel Gallego-Escuredo, et al.AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.AIDS (London, England)|August 6, 2015
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced diseaseMaria Casadellà, Christian Manzardo, Marc Noguera-Julian, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trialJose M Miro, Juan C Lopez, Daniel Podzamczer, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2013
Peak bone mass in young HIV-infected patients compared with healthy controlsEugènia Negredo, Pere Domingo, Elena Ferrer, et al.The Journal of Antimicrobial Chemotherapy|December 25, 2014
Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized studyMaria Saumoy, Jordi Ordóñez-Llanos, Esteban Martínez, et al.The Journal of Antimicrobial Chemotherapy|June 26, 2012
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patientsJoaquin Burgos, Manuel Crespo, Vicenç Falcó, et al.Antiviral Therapy|May 11, 2011
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN TrialVicente Soriano, Keikawus Arastéh, Horacio Migrone, et al.Brain and Behavior|February 9, 2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19Carmen García-Sánchez, Marco Calabria, Nicholas Grunden, et al.The Journal of Antimicrobial Chemotherapy|August 13, 2016
Improved adipose tissue function with initiation of protease inhibitor-only ARTRobert T Maughan, Eoin R Feeney, Emilie Capel, et al.Pageof 38